For the quarter ending 2025-12-31, CLX made $1,673M in revenue. $157M in net income. Net profit margin of 9.38%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net sales | 1,673 | 1,429 | 1,988 | 1,668 |
| Cost of products sold | 951 | 833 | 1,064 | 924 |
| Gross profit | 722 | 596 | 924 | 744 |
| Selling and administrative expenses | 262 | 277 | 296 | 267 |
| Advertising costs | 190 | 166 | 171 | 207 |
| Research and development costs | 29 | 28 | 32 | 27 |
| Loss on divestiture | 0 | 0 | 0 | 0 |
| Pension settlement charge | - | - | 0 | 0 |
| Goodwill, trademark and other asset impairments | - | - | 0 | - |
| Interest expense | 25 | 23 | 22 | 23 |
| Amortization of trademarks and other intangible assets | - | - | - | 5 |
| Trust investment (gains) losses, net | - | - | - | -2 |
| Net periodic benefit cost | - | - | - | 3 |
| Foreign exchange transaction (gains) losses, net | - | - | - | 1 |
| Income from equity investees | - | - | - | 0 |
| Interest income | - | - | - | 2 |
| Restructuring costs | - | - | - | 0 |
| Gain on sale-leaseback transaction | - | - | - | 0 |
| Cyberattack insurance recoveries | - | - | - | 33 |
| Other | - | - | - | -8 |
| Other (income) expense, net | 1 | -5 | -7 | -34 |
| Earnings before income taxes | 215 | 107 | 410 | 254 |
| Income tax expense | 54 | 25 | 74 | 63 |
| Net earnings | 161 | 82 | 336 | 191 |
| Less net earnings attributable to noncontrolling interests | 4 | 2 | 4 | 5 |
| Net earnings attributable to clorox | 157 | 80 | 332 | 186 |
| Basic (in shares) | 121,602,000 | 122,629,000 | -247,403,000 | 123,367,000 |
| Basic net earnings per share (in dollars per share) | 1.29 | 0.65 | 2.7 | 1.51 |
| Diluted (in shares) | 121,915,000 | 123,018,000 | -249,118,000 | 124,066,000 |
| Diluted net earnings per share (in dollars per share) | 1.29 | 0.65 | 2.68 | 1.5 |
CLOROX CO DE (CLX)
CLOROX CO DE (CLX)